Proposed EU Drug Legislation Shortens Data Protection by 6 Months for New Products

The EU’s Environment, Public Health and Food Safety Committee (ENVI) has supported a legislative proposal that would grant up to 7.5 years of regulatory data privacy to pharmaceutical companies developing new drugs, effectively trimming six months of protection from the current eight years for some products.
Source: Drug Industry Daily